Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease

• Published in: Journal of Alzheimer's disease Vol. 99; no. s1; p. S97
• Main Authors: Qaiser, Hammad, Uzair, Mohammad, Al-Regaiey, Khalid, Rafiq, Shafia, Arshad, Muhammad, Yoo, Woo-Kyoung, Arain, Osama Zahid, Kaleem, Imdad, Abualait, Turki, Wang, Lan, Wang, Ran, Bashir, Shahid
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2024
• Subjects: Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Animals; Brain - metabolism; Brain - pathology; Humans; Oxidation-Reduction; Oxidative Stress - physiology; Reactive Oxygen Species - metabolism; Thioredoxin-Disulfide Reductase - metabolism; Thioredoxins - metabolism; Alzheimer’s disease; thioredoxin; reactive oxygen species; antioxidant enzymes; redox enzymes; oxidative stress; thioredoxin reductase
• ISSN: 1875-8908
• DOI: 10.3233/JAD-230394

Alzheimer's disease (AD) is the most common form of dementia and a public health problem. It exhibits significant oxidative stress and redox alterations. The antioxidant enzyme systems defend the cellular environment from oxidative stress. One of the redox systems is the thioredoxin system (TS), which exerts decisive control over the cellular redox environment. We aimed to review the protective effects of TS, which include thioredoxin (Trx), thioredoxin reductase (TrxR), and NADPH. In the following, we discussed the physiological functioning and the role of the TS in maintaining the cellular redox-homeostasis in the AD-damaged brain. Trx protects the cellular environment from oxidative stress, while TrxR is crucial for the cellular detoxification of reactive oxygen species in the brain. However, TS dysregulation increases the susceptibility to cellular death. The changes in Trx and TrxR levels are significantly associated with AD progression. Though the data from human, animal, and cellular models support the neuroprotective role of TS in the brain of AD patients, the translational potential of these findings to clinical settings is not yet applied. This review summarizes the current knowledge on the emerging role of the TrxR-Trx system in AD.